CSL
CSL is rated a buy.
China New Economy ETF
VanEck China New Economy is rated a buy.
Global Healthcare ETF
VanEck Global Healthcare Leaders is rated a buy.
Closed Positions: High Conviction Model
S&P Biotech
Global X S&P Biotech is under Algo Engine buy conditions.
Lynas
ASX:LYN is under Algo Engine buy conditions.
Watch Last Night’s Webinar
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
S&P 500
The S&P 500’s forward annual earnings per share are tracking at $260, $100 higher than six years ago. The P/E on a forward estimate is 23x. The earnings yield is 4.39%, nearing the June 2020 low of 4.11%.
ASX 200 Investor Model
In the last 30 days, the following positions have been added to our longer-term investor model portfolio. We’ll take a closer look at the opportunities in tonight’s webinar.
ASX 200 Trade Table
Many positions have built up in the trade table, and we’ll review them during tonight’s webinar.
Level 29 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
Send our ASX Research to your Inbox
Or start a free thirty day trial for our full service, which includes our ASX Research.